JP2016028092A5 - - Google Patents

Download PDF

Info

Publication number
JP2016028092A5
JP2016028092A5 JP2015191866A JP2015191866A JP2016028092A5 JP 2016028092 A5 JP2016028092 A5 JP 2016028092A5 JP 2015191866 A JP2015191866 A JP 2015191866A JP 2015191866 A JP2015191866 A JP 2015191866A JP 2016028092 A5 JP2016028092 A5 JP 2016028092A5
Authority
JP
Japan
Prior art keywords
compounds described
therapeutic methods
therapeutic
methods
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015191866A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016028092A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2016028092A publication Critical patent/JP2016028092A/ja
Publication of JP2016028092A5 publication Critical patent/JP2016028092A5/ja
Pending legal-status Critical Current

Links

JP2015191866A 2010-05-26 2015-09-29 ヘテロアリール化合物及びその使用方法 Pending JP2016028092A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34868310P 2010-05-26 2010-05-26
US61/348,683 2010-05-26
US41141010P 2010-11-08 2010-11-08
US61/411,410 2010-11-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013512231A Division JP5911476B2 (ja) 2010-05-26 2011-05-26 ヘテロアリール化合物及びその使用方法

Publications (2)

Publication Number Publication Date
JP2016028092A JP2016028092A (ja) 2016-02-25
JP2016028092A5 true JP2016028092A5 (enExample) 2016-06-30

Family

ID=45004801

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013512231A Expired - Fee Related JP5911476B2 (ja) 2010-05-26 2011-05-26 ヘテロアリール化合物及びその使用方法
JP2015191866A Pending JP2016028092A (ja) 2010-05-26 2015-09-29 ヘテロアリール化合物及びその使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013512231A Expired - Fee Related JP5911476B2 (ja) 2010-05-26 2011-05-26 ヘテロアリール化合物及びその使用方法

Country Status (10)

Country Link
US (3) US8969349B2 (enExample)
EP (2) EP2576540B1 (enExample)
JP (2) JP5911476B2 (enExample)
CN (1) CN103038229B (enExample)
AU (1) AU2011258217B2 (enExample)
CA (1) CA2800618C (enExample)
IL (2) IL223240B (enExample)
MX (1) MX351368B (enExample)
NZ (2) NZ603789A (enExample)
WO (1) WO2011150156A2 (enExample)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG187426A1 (en) 2008-01-04 2013-02-28 Intellikine Llc Certain chemical entities, compositions and methods
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
EP2343294A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
TWI487705B (zh) * 2009-12-17 2015-06-11 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物
AU2011258217B2 (en) 2010-05-26 2016-12-15 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
EP3238722B1 (en) 2011-01-10 2019-03-13 Infinity Pharmaceuticals, Inc. Solid forms of isoquinolinones
CA2824047C (en) 2011-01-11 2019-06-18 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
RU2013142364A (ru) 2011-02-18 2015-03-27 Аллерган, Инк. Замещенные производные 6,7-диалкокси-3-изохинолинола в качестве ингибиторов фосфодиэстеразы 10 (фдэ10а)
WO2013005798A1 (ja) * 2011-07-06 2013-01-10 持田製薬株式会社 新規含窒素複素環誘導体
WO2013050527A1 (en) * 2011-10-05 2013-04-11 H. Lundbeck A/S Quinazoline derivatives as pde10a enzyme inhibitors
AR089361A1 (es) * 2011-12-21 2014-08-20 Lundbeck & Co As H Derivados de quinolina como inhibidores de la enzima pde10a
US9138494B2 (en) * 2011-12-23 2015-09-22 Abbvie Inc. Radiolabeled PDE10A ligands
KR101666293B1 (ko) 2012-05-30 2016-10-13 에프. 호프만-라 로슈 아게 Pde10 억제제로서 트라이아졸로 화합물
RU2014150494A (ru) * 2012-05-30 2016-07-20 Ф. Хоффманн-Ля Рош Аг Пирролидиногетероциклы
MX359146B (es) * 2012-06-15 2018-09-17 Curegenix Inc Compuesto como inhibidor de señalización wnt, composición y uso de los mismos.
IN2015DN00345A (enExample) * 2012-06-19 2015-06-12 Sunovion Pharmaceuticals Inc
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
WO2014028479A1 (en) * 2012-08-13 2014-02-20 Envoy Therapeutics, Inc. Quinoxaline derivatives as gpr6 modulators
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
EP2914296B2 (en) 2012-11-01 2021-09-29 Infinity Pharmaceuticals, Inc. Treatment of cancers using pi3 kinase isoform modulators
CA2889906A1 (en) * 2012-11-29 2014-06-05 Sunovion Pharmaceuticals Inc. Triazolo-pyrazine derivatives useful in the treatment of disorders of the central nervous system
JP6125663B2 (ja) 2012-12-21 2017-05-10 ギリアード カリストガ エルエルシー ホスファチジルイノシトール３−キナーゼ阻害剤としての置換ピリミジンアミノアルキル−キナゾロン
ES2685568T3 (es) 2012-12-21 2018-10-10 Gilead Calistoga Llc Inhibidores de la isoquinolinona o quinazolinona fosfatidilinositol 3-quinasa
ES2480341B1 (es) 2013-01-24 2015-01-22 Palobiofarma S.L Nuevos derivados de pirimidina como inhibidores de la fosfodiesterasa 10 (PDE-10)
US8901144B2 (en) 2013-02-07 2014-12-02 Scifluor Life Sciences, Llc Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
ES2763556T3 (es) 2013-02-07 2020-05-29 Scifluor Life Sciences Inc Antagonistas fluorados de integrina
KR102280614B1 (ko) 2013-03-15 2021-07-21 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
EP2975037A4 (en) * 2013-03-15 2016-08-10 Daiichi Sankyo Co Ltd benzothiophene derivative
AU2013385618B2 (en) * 2013-04-02 2017-01-05 Annji Pharmaceutical Co., Ltd. Multifunctional quinoline derivatives as anti-neurodegenerative agents
US9302992B2 (en) 2013-04-02 2016-04-05 Annji Pharmaceutical Co., Ltd. Multifunctional quinoline derivatives as anti-neurodegenerative agents
US9193736B2 (en) 2013-06-11 2015-11-24 Janssen Pharmaceutica, Nv PDE 10a inhibitors for the treatment of type II diabetes
WO2014200885A1 (en) * 2013-06-11 2014-12-18 Janssen Pharmaceutica Nv PDE10a INHIBITORS FOR THE TREATMENT OF TYPE II DIABETES
BR112015031475A2 (pt) 2013-06-14 2017-07-25 Gilead Sciences Inc composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto.
US9453002B2 (en) 2013-08-16 2016-09-27 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
EP3074387B1 (en) * 2013-11-28 2017-11-08 F.Hoffmann-La Roche Ag Imidazole derivatives
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
JP6526034B2 (ja) 2014-02-14 2019-06-05 武田薬品工業株式会社 Ｇｐｒ６のピリドピラジンモジュレーター
WO2015160975A2 (en) 2014-04-16 2015-10-22 Infinity Pharmaceuticals, Inc. Combination therapies
CN107531699A (zh) 2015-02-19 2018-01-02 赛弗卢尔生命科学公司 氟化四氢萘啶基壬酸衍生物及其用途
MX383376B (es) * 2015-03-24 2025-03-13 Shanghai Yingli Pharm Co Ltd Derivado de un anillo condensado y método de preparación, compuesto intermedio, composición farmacéutica y uso del mismo.
WO2016160362A1 (en) 2015-03-31 2016-10-06 Allergan, Inc. Cyclosporins modified on the mebmt sidechain by heterocyclic rings
EP3325473A4 (en) * 2015-07-22 2019-06-26 The Royal Institution for the Advancement of Learning / McGill University Compounds and uses thereof in the treatment of cancer and other medical disorders
DE102015011861B4 (de) 2015-09-10 2018-03-01 Rudolf Schindler Neue cyclische Carboxamide als NMDA NR2B Rezeptor Inhibitoren
JP6916175B2 (ja) 2015-10-26 2021-08-11 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 有害生物防除剤としての縮合二環式ヘテロ環誘導体
DK3464272T3 (da) 2016-06-07 2022-02-21 Jacobio Pharmaceuticals Co Ltd Nye heterocykliske derivater som SHP2-inhibitorer
ES2993451T3 (en) 2016-06-13 2024-12-30 Glaxosmithkline Ip Dev Ltd Substituted pyridines as inhibitors of dnmt1
US11147818B2 (en) 2016-06-24 2021-10-19 Infinity Pharmaceuticals, Inc. Combination therapies
JP7112384B2 (ja) * 2016-07-07 2022-08-03 サイクレリオン・セラピューティクス，インコーポレーテッド 可溶性グアニル酸シクラーゼ刺激剤の新規な調製方法
US10906888B2 (en) 2016-07-14 2021-02-02 Pfizer Inc. Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
EP3538528B1 (en) 2016-11-08 2020-12-23 Bristol-Myers Squibb Company Pyrrole amides as alpha v integrin inhibitors
KR102317480B1 (ko) 2017-03-23 2021-10-25 자코바이오 파마슈티칼스 컴퍼니 리미티드 Shp2 억제제로서 유용한 신규한 헤테로환형 유도체
AU2018334272B2 (en) * 2017-09-15 2023-06-15 Forma Therapeutics, Inc. Tetrahydro-imidazo quinoline compositions as CBP/p300 inhibitors
WO2019094319A1 (en) 2017-11-07 2019-05-16 Bristol-Myers Squibb Company Pyrrolopyrazine derivatives as alpha v integrin inhibitors
CN107793353A (zh) * 2017-11-08 2018-03-13 中山大学 牛奶树碱类化合物及其应用
EP3587418B1 (en) * 2018-06-29 2021-09-01 Forma Therapeutics, Inc. Inhibitors of creb binding protein (cbp)
KR102805503B1 (ko) * 2018-06-29 2025-05-09 포르마 세라퓨틱스 인크. Creb 결합 단백질(cbp)의 저해
EP3853234B1 (en) 2018-09-18 2025-04-23 Nikang Therapeutics, Inc. Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors
US20210393623A1 (en) 2018-09-26 2021-12-23 Jacobio Pharmaceuticals Co., Ltd. Novel Heterocyclic Derivatives Useful as SHP2 Inhibitors
US12351577B2 (en) 2019-03-15 2025-07-08 Forma Therapeutics, Inc. Inhibiting cyclic AMP-responsive element-binding protein (CREB)
CA3132995A1 (en) * 2019-03-15 2020-09-24 Forma Therapeutics, Inc. Compositions and methods for treating androgen receptor positive forms of cancer
JPWO2021070957A1 (enExample) * 2019-10-09 2021-04-15
US11801243B2 (en) 2020-09-23 2023-10-31 Forma Therapeutics, Inc. Bromodomain inhibitors for androgen receptor-driven cancers
US11795168B2 (en) 2020-09-23 2023-10-24 Forma Therapeutics, Inc. Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
CN117247360A (zh) * 2023-09-18 2023-12-19 成都伊诺达博医药科技有限公司 一种2-甲氧基-3-(1-甲基-1h-1,2,4-三唑-3-基)苯胺的制备方法

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH348967A (de) * 1956-12-21 1960-09-30 Geigy Ag J R Verfahren zur Herstellung von Benzimidazolen
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3897432A (en) * 1971-04-21 1975-07-29 Merck & Co Inc Substituted benzimidazole derivatives
NL7204972A (enExample) 1971-04-21 1972-10-24
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4036840A (en) * 1972-06-07 1977-07-19 Icn Pharmaceuticals 2-Substituted-s-triazolo[1,5a]pyrimidines
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
US4045564A (en) 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
IT1222412B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
JP2598100B2 (ja) * 1988-08-31 1997-04-09 キヤノン株式会社 電子写真感光体
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5217980A (en) * 1990-07-19 1993-06-08 Janssen Pharmaceutica N.V. Oxazolyl and piperidinyl substituted benimidazolyl compounds
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
JP2646995B2 (ja) * 1993-01-28 1997-08-27 武田薬品工業株式会社 キノリンまたはキナゾリン誘導体およびそれらを含んでなる医薬
IL108524A0 (en) * 1993-02-03 1994-05-30 Gensia Inc Imidazodiazepine analogs
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
JPH0769890A (ja) * 1993-06-29 1995-03-14 Takeda Chem Ind Ltd キノリンまたはキナゾリン誘導体を含んでなる医薬組成物
EP0634169B1 (en) * 1993-06-29 2000-01-05 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
JPH1067658A (ja) * 1995-09-13 1998-03-10 Takeda Chem Ind Ltd 免疫抑制剤
CA2249029A1 (en) * 1996-04-25 1997-10-30 Haruhiko Makino Thienopyridine derivatives and their use
EP1066039A4 (en) * 1998-03-02 2003-02-26 Cocensys Inc SUBSTITUTED QUINAZOLINE AND THEIR ANALOGS AND USES
JPH11279177A (ja) * 1998-03-27 1999-10-12 Taisho Pharmaceut Co Ltd ベンゾチアゾール誘導体
AU3033500A (en) * 1999-01-15 2000-08-01 Agouron Pharmaceuticals, Inc. Non-peptide glp-1 agonists
US6465486B1 (en) * 1999-03-12 2002-10-15 Ortho-Mcneil Pharmaceutical, Inc. Pyridyl/quinolinyl imidazoles
US6355638B1 (en) * 1999-11-25 2002-03-12 Merck Sharp & Dohme Ltd. Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition
US8124625B2 (en) * 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
AU2003261834A1 (en) * 2002-08-30 2004-05-04 Bf Research Institute, Inc. Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
EP1572690A1 (en) * 2002-12-20 2005-09-14 Pharmacia Corporation Thiazole compounds as integrin receptor antagonists derivatives
JP2006513212A (ja) * 2002-12-20 2006-04-20 スリーエム イノベイティブ プロパティズ カンパニー アリール／ヘタリール置換されたイミダゾキノリン
CN1747936A (zh) * 2003-02-12 2006-03-15 特兰斯泰克制药公司 作为治疗试剂的取代吡咯衍生物
BRPI0407573A (pt) * 2003-02-25 2006-02-14 Altana Pharma Ag derivados de imidazo(4,5-b)quinolina e seu emprego como inibidores de sintase de no
KR20060092219A (ko) * 2003-10-01 2006-08-22 알타나 파마 아게 유도성 ｎｏ-합성효소 억제제로서의 아미노피리딘-유도체
KR20060092222A (ko) * 2003-10-01 2006-08-22 알타나 파마 아게 유도성 ｎｏ-합성효소 억제제로서의 이미다조피리딘-유도체
UA86283C2 (uk) * 2005-01-07 2009-04-10 Пфайзер Продактс Инк. Гетероароматичні сполуки хіноліну і їх застосування як інгібіторів pde10
US20060252807A1 (en) * 2005-04-22 2006-11-09 Kalypsys, Inc. Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
NL2000397C2 (nl) 2006-01-05 2007-10-30 Pfizer Prod Inc Bicyclische heteroarylverbindingen als PDE10 inhibitoren.
CA2643044A1 (en) 2006-02-28 2007-09-07 Amgen Inc. Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
CN101484449A (zh) * 2006-04-28 2009-07-15 艾维克有限公司 整合酶抑制剂-3
CA2650976A1 (en) * 2006-05-02 2007-11-15 Pfizer Products Inc. Bicyclic heteroaryl compounds as pde10 inhibitors
TW200815436A (en) * 2006-05-30 2008-04-01 Elbion Ag 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
PE20080992A1 (es) * 2006-06-26 2008-08-06 Enanta Pharm Inc Quinoxalinil macrociclicos inhibidores de serina proteasa del virus de la hepatitis c
WO2008020302A2 (en) * 2006-08-17 2008-02-21 Pfizer Products Inc. Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors
GB0619325D0 (en) * 2006-09-30 2006-11-08 Univ Strathclyde New compounds
ES2381589T3 (es) * 2006-10-19 2012-05-29 F. Hoffmann-La Roche Ag Aminometil-4-imidazoles
US9101628B2 (en) * 2007-09-18 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and composition of treating a flaviviridae family viral infection
PT2562166E (pt) * 2008-01-22 2015-10-28 Dow Agrosciences Llc Derivados de 5-fluoro-pirimidina como fungicidas
EP2300470A2 (en) * 2008-05-19 2011-03-30 Sepracor Inc. Imidazo[1,2-a]pyridine compounds as gaba-a receptor modulators
TWI501965B (zh) * 2008-06-20 2015-10-01 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
EP2168965A1 (en) 2008-09-25 2010-03-31 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine, imidazopyrazine, imidazopyridazine and imidazopyrimidine derivatives as melanocortin-4 receptor antagonists
CA2742602A1 (en) * 2008-11-06 2010-05-14 Schering Corporation Gamma secretase modulators
AU2010242303A1 (en) 2009-04-28 2011-10-13 Msd K.K. Heteroarylthiomethyl pyridine derivative
TW201100411A (en) * 2009-05-21 2011-01-01 Chlorion Pharma Inc Pyrimidines as novel therapeutic agents
WO2011053559A1 (en) * 2009-10-30 2011-05-05 Merck Sharp & Dohme Corp. Aryl aminopyridine pde10 inhibitors
TWI485151B (zh) 2009-12-17 2015-05-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物
WO2011122815A2 (en) * 2010-03-29 2011-10-06 Dong-A Pharm.Co.,Ltd. Novel quinoxaline derivatives
AU2011258217B2 (en) 2010-05-26 2016-12-15 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2016028092A5 (enExample)
JP2016065085A5 (enExample)
IL285650B (en) Hydroponic planter
JP2016028081A5 (enExample)
JP2016196495A5 (enExample)
JP2016502162A5 (enExample)
JP2017214405A5 (enExample)
LT3513809T (lt) Medicininė kompozicija, apimanti tivozanibą
LT3230281T (lt) 1,3-tiazol-2-ilu pakeisti benzamidai
JP2017137500A5 (enExample)
JP2018533683A5 (enExample)
KR20180084876A (ko) 내플라즈마성 부재
DK3402782T3 (da) 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decanderivater
JP2015173751A5 (enExample)
IL262851A (en) Combination prime: boost therapy
JP2015016294A5 (enExample)
JP2019505548A5 (enExample)
UY4430S (es) “motocicleta”.
JP2017149782A5 (enExample)
JP2017528459A5 (enExample)
JP2016053220A5 (enExample)
JP2016047837A5 (enExample)
EP3449805A4 (en) Resectoscope
JP2016054715A5 (enExample)
JP2015043197A5 (enExample)